Latest filing published 22 Jan 2026 for Pliant Therapeutics, INC., €8,285.
Filing timeline
BuySaleInsider track record
Lily Cheung: trading record in brief
Lily Cheung (senior executive) discloses dealings in Pliant Therapeutics, Inc. to SEC (Form 4). Between 23 January 2024 and 20 January 2026, the trades on record add up to 4 filings.
Sales make up the whole of the open-market record (2 sales, €49k). Outside the open market, there are 2 share grants. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 22 January 2026, the filings show an open-market sale worth €8,285 in Pliant Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lily Cheung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,534 shares@ US$1.280.015% mcap16.9% of flowCommon StockSEC:0001746473-26-000010:0
- 25,875 shares0Common StockSEC:0001746473-25-000019:0
- 3,740 shares@ US$11.201183.1% of flowCommon StockSEC:0001746473-25-000002:0
- 26,000 shares0Common StockSEC:0001746473-24-000013:0
4 of 4 declarations